Education
About Us
Working with TipRanks
Follow Us
Paxman AB (PXMBF)
:PXMBF
PXMBF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.80 - $3.50
Previous CloseN/A
Volume298.00
Average Volume (3M)0.00
Market Cap
$120.61M
Enterprise Value$1.08B
Total Cash (Recent Filing)kr40.31M
Total Debt (Recent Filing)kr14.29M
Price to Earnings (P/E)17.6
Beta-0.10
Next Earnings
May 22, 2025EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding19,012,500
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)N/A
Price to Sales (P/S)4.65
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Paxman AB News
PremiumCompany Announcements
Paxman AB Reports Robust Growth and Strategic Advances
PremiumCompany Announcements
Paxman AB Reports Growth with Strategic Advances
PremiumPre-Earnings
Paxman AB (PXMBF) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Is PXMBF a Buy, Before Earnings?
---
PXMBF FAQ
What was Paxman AB’s price range in the past 12 months?
Paxman AB lowest stock price was $2.80 and its highest was $3.50 in the past 12 months.
What is Paxman AB’s market cap?
Paxman AB’s market cap is $120.61M.
When is Paxman AB’s upcoming earnings report date?
Paxman AB’s upcoming earnings report date is May 22, 2025 which is in 39 days.
How were Paxman AB’s earnings last quarter?
Paxman AB released its earnings results on Feb 21, 2025. The company reported $0.06 earnings per share for the quarter, the consensus estimate of $0.06 by $0.
Is Paxman AB overvalued?
According to Wall Street analysts Paxman AB’s price is currently Overvalued.
Does Paxman AB pay dividends?
Paxman AB does not currently pay dividends.
What is Paxman AB’s EPS estimate?
Paxman AB’s EPS estimate is 0.06.
How many shares outstanding does Paxman AB have?
Paxman AB has 19,012,500 shares outstanding.
What happened to Paxman AB’s price movement after its last earnings report?
Paxman AB reported an EPS of $0.06 in its last earnings report, expectations of $0.06. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Paxman AB?
Currently, no hedge funds are holding shares in PXMBF
---
Company Description
Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
---
Technical Analysis
Dignitana AB
―
C-Rad AB Class B
―
IRLAB Therapeutics AB Class A
―
BrainCool AB
―
Sedana Medical AB
―
---